期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | JOURNAL OF UROLOGY LetPub Score 8.0
51 ratings
Rate
Reputation 8.7 Influence 7.1 Speed 9.4 | ||||||||||||||||
期刊簡稱 | J UROLOGY | ||||||||||||||||
ISSN | 0022-5347 | ||||||||||||||||
E-ISSN | 1527-3792 | ||||||||||||||||
h-index | 236 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 6.80%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | http://www.jurology.com/ | ||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/JU | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Elsevier Inc. | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||
創刊年 | 1917 | ||||||||||||||||
每年文章數 | 203每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 6.11% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0022-5347%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Very fast, 2-3 Week(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: Difficult | ||||||||||||||||
在線文章發布時間 | 來自Elsevier的數據: Average 14.5 Week(s) | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 下一頁 末頁 (頁 | |
[JOURNAL OF UROLOGY] 的評論 | 撰寫評論 |
作者: Nabi2022 領域: 医学 審稿時間: 4.0 month(s) 結果: 拒稿 撰寫評論 |
2024-02-08 18:42:19 評論於 Submitted by the end of July, the manuscript went through 3 weeks of review with the Editor, and it took 4 months to receive the results of the external review. There were 3 reviewers, with 2 recommending revisions and 1 rejecting the manuscript, ultimately resulting in rejection. Currently, JU has a large number of submissions, causing the review process to be longer, with an average of 3 months for the first review. JU has published a large number of Letters, presumably to maintain its impact factor. As an established journal, it was only categorized as a second-tier journal by the Chinese Academy of Sciences in 2023(4) 讚! | Nabi2022 |
作者: 坠星成风 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-02 08:38:32 評論於 Excuse me, where did you find the font for this magazine?(0) 讚! | 坠星成风 |
作者: Tammy Adelaide 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-06 23:00:57 評論於 Do I need to pay a review fee? Will my submission be rejected after review?(0) 讚! | Tammy Adelaide |
作者: Littlebush 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-01 19:22:13 評論於 The Journal of Urology is unexpectedly only in the 2nd tier of the Chinese Academy of Sciences. CAS is indeed the ultimate truth in the universe.(1) 讚! | Littlebush |
作者: Pamela Nora 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-12 12:11:20 評論於 Does this magazine currently require a layout fee? Is there a section for submissions in the submission system?(0) 讚! | Pamela Nora |
作者: Everley Whitehead 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-02-02 11:58:53 評論於 Can I submit an article on prostate cancer in molecular biology experiments?(0) 讚! | Everley Whitehead |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 23:43:01 評論於 We suggest dividing the discussion of research limitations into three parts: (1) presenting research limitations; (2) explaining research limitations in detail; and (3) suggesting future research directions or improvement plans. By discussing research limitations in this order, you can clearly present the shortcomings of the research without compromising its quality and validity(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 10:02:57 評論於 It is still necessary to clearly explain the limitations of the research in the paper and to explain how these limitations have affected the conclusions of the paper, so that reviewers and other readers can understand that we have fully considered the limitations of the research. Discussing the limitations of the research work in the discussion section generally makes the article more credible. Thinking about how to overcome these limitations in future research will have a positive effect(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 八坂篷蔚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 16:10:43 評論於 Do we need to specify the limitations of the article in the discussion?(0) 讚! | 八坂篷蔚 |
作者: 八坂篷蔚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 08:00:21 評論於 How to Write about Limitations in a Discussion?(0) 讚! | 八坂篷蔚 |
作者: 清怡可爱吗 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-01 19:47:28 評論於 Any progress with the editor after 10 days?(0) 讚! | 清怡可爱吗 |
作者: 清怡可爱吗 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-01 18:50:34 評論於 Do you have any progress now?(0) 讚! | 清怡可爱吗 |
作者: Leiharlan 領域: 医学 審稿時間: 2.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-08-29 16:25:59 評論於 I have also been with the editor for a month. What is the situation with the original poster?(0) 讚! | Leiharlan |
作者: 璃月安晴 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-08-26 20:20:36 評論於 I'm also wondering, it has been 20 days since my with editor(0) 讚! | 璃月安晴 |
作者: 金山访波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-07-21 23:17:03 評論於 Hello teacher, may I ask if this magazine accepts A case series and literature review? Thank you(0) 讚! | 金山访波 |
作者: pxw1237 領域: 医学 審稿時間: 2.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-04-22 09:39:21 評論於 What's going on with editor for one month? I submitted on March 21st, and it's still with editor on April 22nd. Feeling confused.(0) 讚! | pxw1237 |
作者: hualala 領域: 医学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2021-03-27 21:42:22 評論於 The manuscript review is fast, with a response given within a month. There are a total of 7 reviewers, some of whom are very meticulous while others only provide comments based on the abstract. Overall, the efficiency is very high and they are very responsible.(0) 讚! | hualala |
作者: Han 領域: 医学 審稿時間: 2.0 month(s) 結果: 拒稿 撰寫評論 |
2021-03-12 08:34:01 評論於 2022.03.12 Rejection. Three reviewers, one of whom provided me with 18 suggestions. Thankful! I will make further modifications and then resubmit!(0) 讚! | Han |
作者: Han 領域: 医学 審稿時間: 1.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-03-07 20:38:52 評論於 The text translates to English as: 2021.03.06 Status changed to Required Reviews Completed. We should know the review results in another week. Nervous. If rejected, the next submission will be to BJOG.(0) 讚! | Han |
作者: Han 領域: 医学 審稿時間: 1.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-02-19 21:40:37 評論於 Posted on 2021.02.03, with editor for 2 weeks, sent for external review on 2021.02.16. Currently waiting.(1) 讚! | Han |
作者: Lauren Barnard 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-10-27 08:17:16 評論於 How are you doing now, dear?(0) 讚! | Lauren Barnard |
作者: 黑山醉巧 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-07-21 08:41:20 評論於 How are you doing now?(0) 讚! | 黑山醉巧 |
作者: 风啸格菲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-05-14 23:33:33 評論於 Is nephrology an option?(0) 讚! | 风啸格菲 |
作者: 风啸格菲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-05-14 20:19:53 評論於 May I ask if this is a journal that directly accepts articles related to urology?(0) 讚! | 风啸格菲 |
作者: 风啸格菲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-05-14 15:29:33 評論於 Can I submit in the field of nephrology?(0) 讚! | 风啸格菲 |
首頁 上一頁 1 2 3 下一頁 末頁 (頁 |
Contact us